-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – lenadogene nolparvovec
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lenadogene nolparvovec Drug Details lenadogene nolparvovec (GS-010) is under development for the treatment of...
-
Product Insights
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leber’s hereditary optic neuropathy (LHON) symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age, tobacco smoke, alcohol, cancer-treating drugs, stress-related chemicals, some antibiotics, and cyanogens. The LHON pipeline drugs market research report provides an analysis of the LHON drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Retinal Degeneration Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Retinal Degeneration Global Clinical Trials Review, H2, 2018" provides an overview of Retinal Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Retinal Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2018" provides an overview of Retinitis Pigmentosa (Retinitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Retinal Degeneration Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Retinal Degeneration Global Clinical Trials Review, H2, 2016" provides an overview of Retinal Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Retinal Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others
GlobalData’s “United States Wound Care Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Wound Care Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags, Oxygen Therapy Devices, Pressure Relief Devices, Surgical Sutures, Tissue Engineered - Skin Substitutes, Traditional Wound Management, Wound Closure Devices and Wound Debridement Devices. The...
-
Sector Analysis
North America Advanced Wound Management Market Outlook to 2025
GlobalData’s “North America Advanced Wound Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Advanced Wound Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels, Semi-Permeable Films, Superabsorbents and Wound Contact Layers. The North America Advanced Wound Management Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices...
-
Sector Analysis
United States Advanced Wound Management Market Outlook to 2025
GlobalData’s “United States Advanced Wound Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Advanced Wound Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels, Semi-Permeable Films, Superabsorbents and Wound Contact Layers. The United States Advanced Wound Management Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices...
-
Product Insights
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Disease – Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Global Clinical Trials Review, H2, 2019" provides an overview of Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) clinical trials scenario. This report provides top line data relating to the clinical trials on Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country...
-
Thematic Analysis
The State of Personalized/Precision Medicine
Personalized/Precision medicine is a field of medicine that uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat diseases. In cancer, personalized medicine uses specific information about an individual to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. The state of personalized/precision medicines market research report covers current and future challenges for the development and launch of these medicines.